Amneal Pharmaceuticals Inc (AMRX)
6.215
+0.10
(+1.64%)
USD |
NASDAQ |
May 02, 16:00
6.21
0.00 (0.00%)
After-Hours: 20:00
Amneal Pharmaceuticals Total Assets (Quarterly): 3.473B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 3.473B |
| September 30, 2023 | 3.687B |
| June 30, 2023 | 3.701B |
| March 31, 2023 | 3.627B |
| December 31, 2022 | 3.799B |
| September 30, 2022 | 3.874B |
| June 30, 2022 | 4.041B |
| March 31, 2022 | 3.889B |
| December 31, 2021 | 3.940B |
| September 30, 2021 | 3.974B |
| June 30, 2021 | 4.023B |
| March 31, 2021 | 3.960B |
| Date | Value |
|---|---|
| December 31, 2020 | 4.006B |
| September 30, 2020 | 4.038B |
| June 30, 2020 | 4.057B |
| March 31, 2020 | 4.391B |
| December 31, 2019 | 3.666B |
| September 30, 2019 | 3.704B |
| June 30, 2019 | 4.262B |
| March 31, 2019 | 4.385B |
| December 31, 2018 | 4.353B |
| September 30, 2018 | 4.582B |
| June 30, 2018 | 4.545B |
| December 31, 2017 | 1.342B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
3.473B
Minimum
Dec 2023
4.391B
Maximum
Mar 2020
3.901B
Average
3.940B
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Fate Therapeutics Inc | 506.22M |
| Ocular Therapeutix Inc | 252.06M |
| Editas Medicine Inc | 499.15M |
| AnaptysBio Inc | 452.39M |
| Stoke Therapeutics Inc | 228.34M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 3.453B |
| Shareholders Equity (Quarterly) | 19.78M |
| Debt to Equity Ratio | 133.49 |
| Current Ratio | 1.628 |
| Net Debt Paydown Yield | 1.03% |